Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of 15.05% is 17% above its 5-year average of 12.82%, near the high end of its 5-year range (7.22%–17.68%).
As of the fiscal period ended Tuesday, June 30, 2026. 5.40% above its 12-month average of 14.28%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): 15.05%.
RETURN ON EQUITY (ROE)
15.05%
RETURN ON EQUITY (ROE) AVG TTM
14.28%
RETURN ON EQUITY (ROE) AVG 3Y
11.91%
RETURN ON EQUITY (ROE) AVG 5Y
12.82%
RETURN ON EQUITY (ROE) AVG 10Y
13.09%
RETURN ON EQUITY (ROE) AVG 15Y
14.33%
RETURN ON EQUITY (ROE) AVG 20Y
15.80%
CURRENT VS TTM AVG
+5.40%
CURRENT VS 3Y AVG
+26.42%
CURRENT VS 5Y AVG
+17.45%
CURRENT VS 10Y AVG
+14.97%
CURRENT VS 15Y AVG
+5.08%
CURRENT VS 20Y AVG
-4.71%
SECTOR MEDIAN · HEALTHCARE
13.01%
median of 84 covered companies
CURRENT VS SECTOR MEDIAN
+15.71%
vs the sector median at left
Cigna Corporation
Market Cap
$76.15B
Return on Equity (ROE)
15.05%
TTM Avg
14.28%
3Y Avg
11.91%
5Y Avg
12.82%
Market Cap
$80.01B
Return on Equity (ROE)
13.65%
TTM Avg
14.72%
3Y Avg
15.95%
5Y Avg
23.11%
Market Cap
$65.30B
Return on Equity (ROE)
14.71%
TTM Avg
10.21%
3Y Avg
8.16%
5Y Avg
6.40%
Market Cap
$62.66B
Return on Equity (ROE)
86.03%
TTM Avg
168.34%
3Y Avg
-32.99%
5Y Avg
148.52%
Market Cap
$90.77B
Return on Equity (ROE)
11.06%
TTM Avg
13.69%
3Y Avg
14.71%
5Y Avg
14.93%
Market Cap
$91.60B
Return on Equity (ROE)
N/A
TTM Avg
-171.53%
3Y Avg
-210.62%
5Y Avg
-155.29%
Market Cap
$56.92B
Return on Equity (ROE)
-46.61%
TTM Avg
-32.64%
3Y Avg
-13.90%
5Y Avg
0.25%
Market Cap
$54.68B
Return on Equity (ROE)
N/A
TTM Avg
-57.79%
3Y Avg
-38.31%
5Y Avg
2.19%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cigna Corporation (CI) | $76.15B | 15.05% | 14.28% | 11.91% | 12.82% |
| Regeneron Pharmaceuticals, Inc. (REGN)vs › | $80.01B | 13.65% | 14.72% | 15.95% | 23.11% |
| Boston Scientific Corporation (BSX)vs › | $65.30B | 14.71% | 10.21% | 8.16% | 6.40% |
| Cencora, Inc. (COR)vs › | $62.66B | 86.03% | 168.34% | -32.99% | 148.52% |
| Elevance Health Inc. (ELV)vs › | $90.77B | 11.06% | 13.69% | 14.71% | 14.93% |
| HCA Healthcare, Inc. (HCA)vs › | $91.60B | N/A | -171.53% | -210.62% | -155.29% |
| Moderna, Inc. (MRNA)vs › | $56.92B | -46.61% | -32.64% | -13.90% | 0.25% |
| Cardinal Health, Inc. (CAH)vs › | $54.68B | N/A | -57.79% | -38.31% | 2.19% |
| GSK plc (GSK)vs › | $99.95B | 27.67% | 26.90% | 55.97% | 45.70% |
| Becton, Dickinson and Company (BDX)vs › | $50.19B | 3.85% | 6.60% | 6.50% | 6.42% |
ROE
15.1%
ROA
4.1%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | 15.05% |
| 2026-03-31 | 14.90% |
| 2025-12-31 | 14.28% |
| 2025-09-30 | 14.70% |
| 2025-06-30 | 12.48% |
| 2025-03-31 | 12.51% |
| 2024-12-31 | 8.37% |
| 2024-09-30 | 7.22% |
| 2024-06-30 | 8.97% |
| 2024-03-31 | 8.79% |
| 2023-12-31 | 11.17% |
| 2023-09-30 | 11.66% |
| 2023-06-30 | 14.69% |
| 2023-03-31 | 15.22% |
| 2022-12-31 | 14.94% |
| 2022-09-30 | 14.71% |
| 2022-06-30 | 11.97% |
| 2022-03-31 | 11.72% |
| 2021-12-31 | 11.39% |
| 2021-09-30 | 17.68% |
| 2021-06-30 | 16.73% |
| 2021-03-31 | 17.52% |
| 2020-12-31 | 16.81% |
| 2020-09-30 | 11.03% |
| 2020-06-30 | 11.11% |
| 2020-03-31 | 10.91% |
| 2019-12-31 | 11.26% |
| 2019-09-30 | 9.56% |
| 2019-06-30 | 8.43% |
| 2019-03-31 | 7.29% |
| 2018-12-31 | 6.43% |
| 2018-09-30 | 17.74% |
| 2018-06-30 | 17.28% |
| 2018-03-31 | 17.99% |
| 2017-12-31 | 16.29% |
| 2017-09-30 | 16.63% |
| 2017-06-30 | 15.46% |
| 2017-03-31 | 13.68% |
| 2016-12-31 | 13.60% |
| 2016-09-30 | 13.68% |
| 2016-06-30 | 14.99% |
| 2016-03-31 | 16.41% |
| 2015-12-31 | 17.40% |
| 2015-09-30 | 18.13% |
| 2015-06-30 | 18.80% |
| 2015-03-31 | 19.26% |
| 2014-12-31 | 19.51% |
| 2014-09-30 | 17.89% |
| 2014-06-30 | 18.42% |
| 2014-03-31 | 18.44% |
| 2013-12-31 | 13.97% |
| 2013-09-30 | 15.40% |
| 2013-06-30 | 14.67% |
| 2013-03-31 | 13.55% |
| 2012-12-31 | 16.61% |
| 2012-09-30 | 15.81% |
| 2012-06-30 | 13.57% |
| 2012-03-31 | 14.43% |
| 2011-12-31 | 15.30% |
| 2011-09-30 | 18.66% |
| 2011-06-30 | 20.83% |
| 2011-03-31 | 21.00% |
| 2010-12-31 | 20.24% |
| 2010-06-30 | 20.68% |
| 2010-03-31 | 23.74% |
| 2009-12-31 | 24.04% |
| 2009-09-30 | 14.80% |
| 2009-06-30 | 13.48% |
| 2009-03-31 | 11.54% |
| 2008-12-31 | 8.13% |
| 2008-09-30 | 16.46% |
| 2008-06-30 | 20.15% |
| 2008-03-31 | 18.36% |
| 2007-12-31 | 23.48% |
| 2007-09-30 | 25.59% |
| 2007-06-30 | 25.37% |
| 2007-03-31 | 26.30% |
| 2006-12-31 | 26.67% |
| 2006-09-30 | 26.61% |
| 2006-06-30 | 23.31% |
| 2006-03-31 | 28.79% |
| 2005-12-31 | 30.32% |
| 2005-09-30 | 34.29% |
| 2005-06-30 | 33.83% |
| 2005-03-31 | 33.40% |
| 2004-12-31 | 27.00% |
| 2004-09-30 | 25.42% |
| 2004-06-30 | 24.74% |
| 2004-03-31 | 10.80% |
| 2003-12-31 | 14.78% |
| 2003-09-30 | 10.04% |
| 2003-06-30 | -15.36% |
